Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Todos Med Ltd (CE) | TOMDF | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.000001 | 0.000001 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 0.000001 - 0.0014 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 0.000001 | USD |
Todos Med Ltd (CE) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 2.57k | 2.57B | 607.86M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Todos Med (CE) News
Date | Time | Source | News Article |
---|---|---|---|
7/17/2023 | 07:29 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TOMDF Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.000001 | 0.000001 | 0.000001 | 0.000001 | 360,758 | 0.00 | 0.00% |
1 Month | 0.000001 | 0.0001 | 0.000001 | 0.0000041 | 152,769 | 0.00 | 0.00% |
3 Months | 0.0002 | 0.0002 | 0.000001 | 0.0001612 | 1,676,476 | -0.0002 | -99.50% |
6 Months | 0.0004 | 0.0005 | 0.000001 | 0.0002552 | 14,239,315 | -0.0004 | -99.75% |
1 Year | 0.0008 | 0.0014 | 0.000001 | 0.0004282 | 11,769,079 | -0.0008 | -99.88% |
3 Years | 0.0329 | 0.644 | 0.000001 | 0.0148137 | 9,475,057 | -0.0329 | -100.00% |
5 Years | 0.23 | 0.644 | 0.000001 | 0.0211729 | 6,361,920 | -0.23 | -100.00% |
Todos Med (CE) Description
Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The Company's state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that examines cancer's influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos' two internally developed cancer-screening tests, TMB-1 and TMB-2 have received a CE mark in Europe. Todos recently acquired U.S.-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab currently performing PCR COVID testing, Long COVID Panel, and Provista's proprietary commercial-stage Videssa breast cancer blood test. |